News and Trends 9 Apr 2025
The biotech job market in 2025: Still in survival mode?
The biotech job market has been tough the last few years but is it getting better? Delve into the industry’s job market in 2025.
News and Trends
- Latest Posts
News and Trends 4 Apr 2025
Developing drugs from outer space: Exobiosphere raises €2 million
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
News and Trends 2 Apr 2025
Top biotech deals of March 2025
Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations.
News and Trends 31 Mar 2025
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals.
News and Trends 25 Mar 2025
AbbVie and Genmab: Can a legal battle break a billion-dollar bond?
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.
News and Trends 24 Mar 2025
First-ever RIPTAC enters clinic: all you need to know about this new cancer approach
The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 21 Mar 2025
Depression drug trials are failing—and placebos are to blame
In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.
News and Trends 10 Mar 2025
23andMe: the collapse of a genomics giant
23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?
News and Trends 6 Mar 2025
Top biotech deals of February 2025
Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.
News and Trends 24 Feb 2025
Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?
This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues.
News and Trends 19 Feb 2025
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?
News and Trends 13 Feb 2025
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs.
ADVERTISEMENT
